Holen Sie sich die Stockscreener-App
1.54
1.32%
0.02
Handel nachbörslich:
1.57
0.03
+1.95%
Schlusskurs vom Vortag:
$1.52
Offen:
$1.47
24-Stunden-Volumen:
117.56K
Relative Volume:
0.60
Marktkapitalisierung:
$17.59M
Einnahmen:
$996.00K
Nettoeinkommen (Verlust:
$-6.09M
KGV:
-2.9057
EPS:
-0.53
Netto-Cashflow:
$-9.76M
1W Leistung:
-5.81%
1M Leistung:
+23.20%
6M Leistung:
+2.67%
1J Leistung:
+19.38%
1-Tages-Spanne:
$1.4446
$1.5808
1-Wochen-Bereich:
$1.4446
$2.10
52-Wochen-Spanne:
$0.70
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
Firmenname
Therapeuticsmd Inc
Sektor
Telefon
561-961-1900
Adresse
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Vergleichen Sie TXMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.54 | 17.59M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
118.14 | 52.35B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.07 | 44.67B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.61 | 43.10B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
VTRS
Viatris Inc
|
10.71 | 12.28B | 14.33B | -3.79B | 1.84B | -3.17 |
|
UTHR
United Therapeutics Corp
|
476.59 | 20.32B | 3.08B | 1.24B | 1.07B | 25.61 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-08-07 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-05-19 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-12-02 | Eingeleitet | Guggenheim | Buy |
| 2019-10-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-04-30 | Fortgesetzt | Noble Capital Markets | Outperform |
| 2018-06-15 | Eingeleitet | JP Morgan | Overweight |
| 2017-09-08 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2017-07-11 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2017-05-09 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2016-11-22 | Fortgesetzt | Jefferies | Buy |
| 2016-11-22 | Eingeleitet | Oppenheimer | Outperform |
| 2016-11-07 | Fortgesetzt | Guggenheim | Buy |
| 2016-04-04 | Eingeleitet | Goldman | Buy |
| 2015-12-08 | Bestätigt | Jefferies | Buy |
| 2015-12-08 | Bestätigt | Stifel | Buy |
| 2015-09-21 | Bestätigt | Jefferies | Buy |
| 2015-06-09 | Eingeleitet | Guggenheim | Buy |
| 2014-07-08 | Eingeleitet | FBR Capital | Outperform |
| 2014-04-17 | Bestätigt | Noble Financial | Buy |
| 2014-01-28 | Bestätigt | Noble Financial | Buy |
Alle ansehen
Therapeuticsmd Inc Aktie (TXMD) Neueste Nachrichten
Will TherapeuticsMD Inc. stock beat EPS estimates2025 EndofYear Setup & Growth Focused Stock Reports - newser.com
Will TherapeuticsMD Inc. (29TA) stock hit Wall Street targets2025 Market Overview & Fast Exit/Entry Strategy Plans - newser.com
Is TherapeuticsMD Inc. stock a buy before product launchesTrade Analysis Report & Fast Momentum Entry Tips - newser.com
Is TherapeuticsMD Inc. (29TA) stock a contrarian opportunityWeekly Profit Analysis & High Yield Stock Recommendations - newser.com
Editor: 【Stock Market Forum】 - newser.com
Is TherapeuticsMD Inc. (29TA) stock supported by strong fundamentals2025 Macro Impact & AI Forecasted Stock Moves - newser.com
Can TherapeuticsMD Inc. stock hit analyst price targetsWeekly Trade Review & Daily Chart Pattern Signal Reports - newser.com
Will TherapeuticsMD Inc. (29TA) stock outperform energy sector in 2025Buy Signal & Consistent Return Investment Signals - newser.com
Can TherapeuticsMD Inc. (29TA) stock test all time highsIPO Watch & Safe Capital Preservation Plans - newser.com
How TherapeuticsMD Inc. (29TA) stock compares with tech leadersMarket Growth Report & Technical Analysis for Trade Confirmation - newser.com
Will TherapeuticsMD Inc. stock see insider buyingAnalyst Downgrade & Safe Entry Trade Signal Reports - newser.com
Trend analysis for TherapeuticsMD Inc. this weekQuarterly Portfolio Review & Entry Point Confirmation Signals - newser.com
How to manage a losing position in TherapeuticsMD Inc.2025 Trading Volume Trends & Accurate Trade Setup Notifications - newser.com
Can a trend reversal in TherapeuticsMD Inc. lead to recovery2025 Market Trends & Weekly Watchlist for Hot Stocks - newser.com
Can TherapeuticsMD Inc. stock weather global recessionPortfolio Return Summary & Reliable Volume Spike Alerts - newser.com
Why TherapeuticsMD Inc. stock remains a top recommendationJuly 2025 Market Mood & Real-Time Stock Movement Alerts - newser.com
Can TherapeuticsMD Inc. (29TA) stock hit consensus price targetsNew Guidance & Stock Market Timing Techniques - Fundação Cultural do Pará
TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors - 富途牛牛
Finanzdaten der Therapeuticsmd Inc-Aktie (TXMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.02%
3.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):